Skip to main content
Smart Investors Daily
AO

OTC · AONC

American Oncology Network, Inc.

Healthcare · Medical - Care Facilities

$21.25

Down-$0.76 (-3.45%)

Updated Nov 6, 2026, 11:27 AM

SID Score

3.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
350.98M
P/E ratio
655.43
Dividend yield
0.00%
52-week range
— – —
Volume
100
Avg. volume
759

Price performance · AONC

AONC price history

1M range · 0 trading sessions · Daily adjusted prices

AONC does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest AONC news

The latest Smart Investors Daily articles mentioning AONC.

AONC research

Overview

Company profile and research snapshot.

Company profile

AMER ONCOLOGY NETWORK A

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 1, 2026

Cencora (COR) Stock Still Looks Undervalued After Its 173% Run

Cencora has put up a powerful long term share price performance, yet the current US$330.84 price invites a sharper question. Are the cash flows behind the business strong enough, and predictable enough, to make that level look well supported? Over the past 5 years the stock is up 172.6%, which puts a lot of weight on whether the underlying cash generation matches the market's enthusiasm. The planned US$2.4b purchase of American Oncology Network can reshape how quickly Cencora converts its...

Yahoo · Nov 1, 2026

Is Cencora (COR) Fully Valued Following Its $2.4b American Oncology Network Deal?

Cencora (COR) has moved into the spotlight after agreeing to buy American Oncology Network in a deal valued at up to US$2.4b. The transaction reshapes its community cancer care footprint. Cencora’s latest move comes after a mixed run in the market, with the share price delivering a 7.05% 1 month return and a 7.29% 3 month share price return. Total shareholder return over 1 year has slipped 1.32% but climbed 172.57% over 5 years, suggesting that long term holders have seen strong compounding...

Yahoo · Oct 31, 2026

What Does Cencora (COR) Gain From Expanding Into 12 More States?

Cencora (NYSE: COR) agreed to acquire American Oncology Network to expand its community-based cancer care footprint. The deal broadens Cencora's physician practice management services into 12 additional states through American Oncology Network's clinic footprint. American Oncology Network brings a network of oncology practices that operates primarily in community settings across the United States. Cencora's purchase of American Oncology Network reshapes its reach in community oncology, but...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.